Targeting mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2295-2303

  Ramón García, Santiago ^a   Mikut, Ralf ^b   Ng, Carol ^a   Ruden, Serge ^b   Volkmer, Rudolf ^b   Reischl, Markus ^b   Hilpert, Kai ^b,c   Thompson, Charles J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CATION; ISOLEUCINE; LEUCINE; LYSINE; POLYPEPTIDE ANTIBIOTIC AGENT; TRYPTOPHAN; VALINE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM; CANDIDA ALBICANS; DRUG CYTOTOXICITY; DRUG TARGETING; FUNGUS; HUMAN; HUMAN CELL; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TAXONOMY;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; ANTITUBERCULAR AGENTS; CANDIDA ALBICANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE LIBRARY; PRINCIPAL COMPONENT ANALYSIS; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84876254275     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00175-13     Document Type: Article

References (46)

1. Peschel A, Sahl HG. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
2. Fjell CD, Hiss JA, Hancock RE, Schneider G. 2012. Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 11:37-51.
3. Marr AK, Gooderham WJ, Hancock RE. 2006. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6:468-472.
4. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
5. Spindler EC, Hale JD, Giddings TH, Jr, Hancock RE, Gill RT. 2011. Deciphering the mode of action of the synthetic antimicrobial peptide Bac8c. Antimicrob. Agents Chemother. 55:1706-1716.
6. Fantner GE, Barbero RJ, Gray DS, Belcher AM. 2010. Kinetics of antimicrobial peptide activity measured on individual bacterial cells using high-speed atomic force microscopy. Nat. Nanotechnol. 5:280-285.
7. Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, Jansen A, Nielsen AK, Mygind PH, Raventos DS, Neve S, Ravn B, Bonvin AM, De Maria L, Andersen AS, Gammelgaard LK, Sahl HG, Kristensen HH. 2010. Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II. Science 328:1168-1172.
8. Brogden KA. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
9. Kragol G, Lovas S, Varadi G, Condie BA, Hoffmann R, Otvos L, Jr. 2001. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry 40:3016-3026.
10. Hilpert K, McLeod B, Yu J, Elliott MR, Rautenbach M, Ruden S, Burck J, Muhle-Goll C, Ulrich AS, Keller S, Hancock RE. 2010. Short cationic antimicrobial peptides interact with ATP. Antimicrob. Agents Chemother. 54:4480-4483.
11. Gunn JS. 2008. The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol. 16:284-290.
12. Ernst CM, Peschel A. 2011. Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids. Mol. Microbiol. 80:290-299.
13. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. 2007. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol. Microbiol. 66:1136-1147.
14. Shafer WM, Qu X, Waring AJ, Lehrer RI. 1998. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U. S. A. 95:1829-1833.
15. Pranting M, Negrea A, Rhen M, Andersson DI. 2008. Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2. Antimicrob. Agents Chemother. 52:2734-2741.
16. Tzeng YL, Ambrose KD, Zughaier S, Zhou X, Miller YK, Shafer WM, Stephens DS. 2005. Cationic antimicrobial peptide resistance in Neisseria meningitidis. J. Bacteriol. 187:5387-5396.
17. Kraus D, Peschel A. 2008. Staphylococcus aureus evasion of innate antimicrobial defense. Future Microbiol. 3:437-451.
18. Hilpert K, Hancock RE. 2007. Use of luminescent bacteria for rapid screening and characterization of short cationic antimicrobial peptides synthesized on cellulose using peptide array technology. Nat. Protoc. 2:1652-1660.
19. Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE. 2006. Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem. Biol. 13:1101-1107.
20. Hilpert K, Volkmer-Engert R, Walter T, Hancock RE. 2005. Highthroughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 23:1008-1012.
21. Fjell CD, Jenssen H, Hilpert K, Cheung WA, Pante N, Hancock RE, Cherkasov A. 2009. Identification of novel antibacterial peptides by chemoinformatics and machine learning. J. Med. Chem. 52:2006-2015.
22. Cherkasov A, Hilpert K, Jenssen H, Fjell CD, Waldbrook M, Mullaly SC, Volkmer R, Hancock RE. 2009. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem. Biol. 4:65-74.
23. Mikut R, Hilpert K. 2009. Interpretable features for the activity prediction of short antimicrobial peptides using fuzzy logic. Int. J. Pept. Res. Ther. 15:129-137.
24. Mikut R. 2010. Computer-based analysis, visualization, and interpretation of antimicrobial peptide activities. Methods Mol. Biol. 618:287-299.
25. Miyakawa Y, Ratnakar P, Rao AG, Costello ML, Mathieu-Costello O, Lehrer RI, Catanzaro A. 1996. In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect. Immun. 64:926-932.
26. Sonawane A, Santos JC, Mishra BB, Jena P, Progida C, Sorensen OE, Gallo R, Appelberg R, Griffiths G. 2011. Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages. Cell. Microbiol. 13: 1601-1617.
27. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773.
28. Linde CM, Hoffner SE, Refai E, Andersson M. 2001. In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multidrug-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 47: 575-580.
29. Jiang Z, Higgins MP, Whitehurst J, Kisich KO, Voskuil MI, Hodges RS. 2011. Anti-tuberculosis activity of alpha-helical antimicrobial peptides: de novo designed L-and D-enantiomers versus L-and D-LL-37. Protein Pept. Lett. 18:241-252.
30. Maloney E, Stankowska D, Zhang J, Fol M, Cheng QJ, Lun S, Bishai WR, Rajagopalan M, Chatterjee D, Madiraju MV. 2009. The twodomain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides. PLoS Pathog. 5:e1000534. doi:10.1371/journal.ppat .1000534.
31. Ramon-Garcia S, Ng C, Anderson H, Chao JD, Zheng X, Pfeifer T, Av-Gay Y, Roberge M, Thompson CJ. 2011. Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. Antimicrob. Agents Chemother. 55:3861-3869.
32. Bowdish DM, Davidson DJ, Hancock RE. 2005. A reevaluation of the role of host defence peptides in mammalian immunity. Curr. Prot. Pept. Sci. 6:35-51.
33. Hancock RE, Sahl HG. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
34. Hilpert K, Winkler DF, Hancock RE. 2007. Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat. Protoc. 2:1333-1349.
35. Kamradt T, Volkmer-Engert R. 2004. Cross-reactivity of T lymphocytes in infection and autoimmunity. Mol. Divers. 8:271-280.
36. Montoro E, Lemus D, Echemendia M, Martin A, Portaels F, Palomino JC. 2005. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 55:500-505.
37. Brennan PJ, Young DB. 2008. Handbook of anti-tuberculosis agents. Tuberculosis 88:85-170.
38. Wiegand I, Hilpert K, Hancock RE. 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3:163-175.
39. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176.
40. Mikut R, Burmeister O, Braun S, Reischl M. 2008. The open source Matlab toolbox Gait-CAD and its application to bioelectric signal processing, p 109-111. Proc. DGBMT-Workshop Biosignalverarbeitung, Potsdam.
41. Huang Y, Huang J, Chen Y. 2010. Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Prot. Cell 1:143-152.
42. Pick N, Cameron S, Arad D, Av-Gay Y. 2004. Screening of compounds toxicity against human monocytic cell line-THP-1 by flow cytometry. Biol. Proced. Online 6:220-225.
43. Nguyen L, Thompson CJ. 2006. Foundations of antibiotic resistance in bacterial physiology-the mycobacterial paradigm. Trends Microbiol. 14: 304-312.
44. Wilmes M, Cammue BP, Sahl HG, Thevissen K. 2011. Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation. Nat. Prod. Rep. 28:1350-1358.
45. Ortalo-Magne A, Lemassu A, Laneelle MA, Bardou F, Silve G, Gounon P, Marchal G, Daffe M. 1996. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J. Bacteriol. 178:456-461.
46. Stanley SA, Grant SS, Kawate T, Iwase N, Shimizu M, Wivagg C, Silvis M, Kazyanskaya E, Aquadro J, Golas A, Fitzgerald M, Dai H, Zhang L, Hung DT. 2012. Identification of novel inhibitors of M. tuberculosis growth using whole-cell based high-throughput screening. ACS Chem. Biol. 7:1377-1384.